Dr. Herrmann discusses how to monitor and treat cardiotoxicity in cancer patients receiving VEGF inhibitors.
Joerg Herrmann, MD
Advertisement
Articles by Joerg Herrmann, MD
Advertisement
Latest Updated Articles
Detecting Cardiotoxicity in Cancer Patients Receiving VEGF InhibitorsPublished: February 15th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Proton Beam Therapy and IMRT Confer Similar AEs and QOL in Oropharyngeal Cancer
2
T-DXd Improves Invasive DFS vs T-DM1 in HER2+ Early Breast Cancer Subgroup
3
Adding 177Lu-PNT2002 to SBRT Improves PFS in Oligorecurrent Prostate Cancer
4
Certepetide/FOLFIRINOX Displays Encouraging Preliminary Feasibility in PDAC
5
